207 related articles for article (PubMed ID: 23420546)
1. Stereotactic body radiotherapy for pulmonary metastases. Prognostic factors and adverse respiratory events.
Inoue T; Oh RJ; Shiomi H; Masai N; Miura H
Strahlenther Onkol; 2013 Apr; 189(4):285-92. PubMed ID: 23420546
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
3. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
[TBL] [Abstract][Full Text] [Related]
4. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
[TBL] [Abstract][Full Text] [Related]
5. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
[TBL] [Abstract][Full Text] [Related]
6. Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT).
Reyngold M; Wu AJ; McLane A; Zhang Z; Hsu M; Stein NF; Zhou Y; Ho AY; Rosenzweig KE; Yorke ED; Rimner A
Radiat Oncol; 2013 Apr; 8():99. PubMed ID: 23617949
[TBL] [Abstract][Full Text] [Related]
7. Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis.
Aibe N; Yamazaki H; Nakamura S; Tsubokura T; Kobayashi K; Kodani N; Nishimura T; Okabe H; Yamada K
J Radiat Res; 2014 May; 55(3):575-82. PubMed ID: 24457315
[TBL] [Abstract][Full Text] [Related]
8. Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases.
Lee YH; Kang KM; Choi HS; Ha IB; Jeong H; Song JH; Jang IS; Kim SH; Lee JW; Rhee DY; Jeong BK
Thorac Cancer; 2018 Dec; 9(12):1671-1679. PubMed ID: 30298701
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases.
Berkovic P; Gulyban A; Defraene G; Swenen L; Dechambre D; Nguyen PV; Jansen N; Mievis C; Lovinfosse P; Janvary L; Lambrecht M; De Meerleer G
BMC Cancer; 2020 May; 20(1):402. PubMed ID: 32384918
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy for second primary lung cancer and intra-parenchymal lung metastasis in patients previously treated with surgery: evaluation of indications and predictors of decreased respiratory function.
Ishihara T; Yamada K; Harada A; Yukiue H; Tanahashi M; Niwa H; Matsui T; Yokomura K; Ejima Y; Sasaki R
Acta Oncol; 2018 Sep; 57(9):1232-1239. PubMed ID: 29722594
[TBL] [Abstract][Full Text] [Related]
11. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
Parks J; Kloecker G; Woo S; Dunlap NE
Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
14. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO).
Kessel KA; Grosser RCE; Kraus KM; Hoffmann H; Oechsner M; Combs SE
BMC Cancer; 2020 May; 20(1):442. PubMed ID: 32429940
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules.
Owen D; Olivier KR; Mayo CS; Miller RC; Nelson K; Bauer H; Brown PD; Park SS; Ma DJ; Garces YI
Radiat Oncol; 2015 Feb; 10():43. PubMed ID: 25889747
[TBL] [Abstract][Full Text] [Related]
17. The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors.
Kanzaki R; Suzuki O; Kanou T; Ose N; Funaki S; Shintani Y; Minami M; Tamari K; Otani K; Seo Y; Isohashi F; Ogawa K; Okumura M
J Cardiothorac Surg; 2020 Feb; 15(1):43. PubMed ID: 32103767
[TBL] [Abstract][Full Text] [Related]
18. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in stereotactic body radiotherapy of lung metastases.
Borm KJ; Oechsner M; Schiller K; Peeken JC; Dapper H; Münch S; Kroll L; Combs SE; Duma MN
Strahlenther Onkol; 2018 Oct; 194(10):886-893. PubMed ID: 30014235
[TBL] [Abstract][Full Text] [Related]
20. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
